Connect Biopharma Holdings Limited Share Price
NASDAQ: CNTB | Micro CapConnect Biopharma Holdings Limited Stock Performance
Connect Biopharma Holdings Limited Share Price Today
As of 30 October 2026, Connect Biopharma Holdings Limited's share price is $0.83. The stock opened at $0.85, compared to its previous close of $0.85. During today's trading session, Connect Biopharma Holdings Limited's share price traded between $0.83 and $0.85, with an average price of $0.84. Over the past 52 weeks, the stock has recorded a high of $3.74 and a low of $0.73. In terms of performance, Connect Biopharma Holdings Limited's share price has declined by 65.98% over the last six months and is down 51.26% on a year-on-year basis.
Connect Biopharma Holdings Limited Share Price Chart
Connect Biopharma Holdings Limited Quarterly Profit & Loss
All figures in USD
Connect Biopharma Holdings Limited Annual Profit & Loss
All figures in USD
About Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Connect Biopharma Holdings Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.11 | $0.84 | -23.01% |
Sep 2026 | $2.19 | $1.09 | -51.97% |
Aug 2026 | $2.06 | $2.28 | +12.87% |
Jul 2026 | $2.39 | $2.02 | -14.95% |
Jun 2026 | $2.49 | $2.38 | -4.23% |
May 2026 | $2.46 | $2.48 | +1.22% |
Apr 2026 | $2.69 | $2.45 | -5.77% |
Mar 2026 | $2.50 | $2.60 | +4.00% |
Feb 2026 | $2.44 | $2.50 | +2.67% |
Jan 2026 | $2.68 | $2.44 | -13.04% |
Dec 2025 | $2.77 | $2.80 | +1.45% |
Nov 2025 | $1.72 | $2.76 | +61.40% |